Cholinergic system during the progression of Alzheimer’s disease: therapeutic implications
Open accessThe DOI matches its Crossref record; 191 of the 191 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) is characterized by a progressive phenotypic downregulation of markers within cholinergic basal forebrain (CBF) neurons, frank CBF cell loss and reduced cortical choline acetyltransferase activity associated with cognitive decline. Delaying CBF neurodegeneration or minimizing its consequences is the mechanism of action for most currently available drug treatments for cognitive dysfunction in AD. Growing evidence suggests that imbalances in the expression of NGF, its precursor proNGF and the high (TrkA) and low (p75(NTR)) affinity NGF receptors are crucial factors underlying CBF dysfunction in AD. Drugs that maintain a homeostatic balance between TrkA and p75(NTR) may slow the onset of AD. A NGF gene therapy trial reduced cognitive decline and stimulated cholinergic fiber growth in humans with mild AD. Drugs treating the multiple pathologies and clinical symptoms in AD (e.g., M1 cholinoceptor and/or galaninergic drugs) should be considered for a more comprehensive treatment approach for cholinergic dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864
Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. ‐., Nordberg, A., Bäckman, L., Albert, M., Almkvist, O., et al. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01380.x · Cited by 4,946
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565
Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492
Alzheimer's disease: cell-specific pathology isolates the hippocampal formation.
Hyman, B. T., Van Hoesen, G. W., Damasio, A. R., & Barnes, C. L. (1984) · Science · doi:10.1126/science.6474172 · Cited by 2,268
Neurotrophin signal transduction in the nervous system
Kaplan, D. R., & Miller, F. D. (2000) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00092-1 · Cited by 1,944
Bonni, A., Brunet, A., West, A. E., Datta, S. R., Takasu, M. A., & Greenberg, M. E. (1999) · Science · doi:10.1126/science.286.5443.1358 · Cited by 1,901
Mild Cognitive Impairment Represents Early-Stage Alzheimer Disease
Morris, J. C., Storandt, M., Miller, J. P., McKeel, D. W., Price, J. L., Rubin, E. H., & Berg, L. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.397 · Cited by 1,851
Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease
Gómez-Isla, T., Price, J. L., McKeel Jr., D. W., Morris, J. C., Growdon, J. H., & Hyman, B. T. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-14-04491.1996 · Cited by 1,796 · cited 1×
“Alzheimer’s Association, Chicago, IL, USA 204–210 (2004).”
Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis
Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T., & DeLong, M. R. (1981) · Annals of Neurology · doi:10.1002/ana.410100203 · Cited by 1,736
Regulation of Cell Survival by Secreted Proneurotrophins
Lee, R., Kermani, P., Teng, K. K., & Hempstead, B. L. (2001) · Science · doi:10.1126/science.1065057 · Cited by 1,670
Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections
Hefti, F. (1986) · The Journal of Neuroscience · doi:10.1523/jneurosci.06-08-02155.1986 · Cited by 1,450
Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial
Gilman, S., Koller, M., Black, R. S., Jenkins, L., Griffith, S. G., Fox, N. C., Eisner, L., Kirby, L., Rovira, M. B., Forette, F., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000159740.16984.3c · Cited by 1,329
Asher, R. (1961) · The Lancet · doi:10.1016/s0140-6736(61)91217-x · Cited by 1,290
Nerve Growth Factor Signaling, Neuroprotection, and Neural Repair
Sofroniew, M. V., Howe, C. L., & Mobley, W. C. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1217 · Cited by 1,284
Inestrosa, N. C., Alvarez, A., Pérez, C. A., Moreno, R. D., Vicente, M., Linker, C., Casanueva, O. I., Soto, C., & Garrido, J. (1996) · Neuron · doi:10.1016/s0896-6273(00)80108-7 · Cited by 1,101
Trk receptors: mediators of neurotrophin action
Patapoutian, A., & Reichardt, L. F. (2001) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00208-7 · Cited by 1,069
Williams, L. R., Varon, S., Peterson, G. M., Wictorin, K., Fischer, W., Bjorklund, A., & Gage, F. H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.23.9231 · Cited by 1,055
A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease
Tuszynski, M. H., Thal, L., Pay, M., Salmon, D. P., U, H. S., Bakay, R., Patel, P., Blesch, A., Vahlsing, H. L., Ho, G., et al. (2005) · Nature Medicine · doi:10.1038/nm1239 · Cited by 1,050
Self-citationGoedert, M., Spillantini, M. G., Potier, M. C., Ulrich, J., & Crowther, R. A. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03390.x · Cited by 1,037
Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment
Scheff, S. W., Price, D. A., Schmitt, F. A., & Mufson, E. J. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.012 · Cited by 1,017
Self-citationProBDNF Induces Neuronal Apoptosis via Activation of a Receptor Complex of p75NTRand Sortilin
Teng, H. K., Teng, K. K., Lee, R., Wright, S., Tevar, S., Almeida, R. D., Kermani, P., Torkin, R., Chen, Z.-Y., Lee, F. S., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.5123-04.2005 · Cited by 1,013
Sortilin is essential for proNGF-induced neuronal cell death
Nykjaer, A., Lee, R., Teng, K. K., Jansen, P., Madsen, P., Nielsen, M. S., Jacobsen, C., Kliemannel, M., Schwarz, E., Willnow, T. E., et al. (2004) · Nature · doi:10.1038/nature02319 · Cited by 962 · cited 2×
“63(1), 38–46 (2006). Morris JC, Storandt M, Miller JP 9 et al.”
Bartus, R. T. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7397 · Cited by 829
β-Amyloid1–42 Binds to α7 Nicotinic Acetylcholine Receptor with High Affinity
Wang, H.-Y., Lee, D. H. S., D'Andrea, M. R., Peterson, P. A., Shank, R. P., & Reitz, A. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.5626 · Cited by 822
Activation of the MAP kinase pathway by the protein kinase raf
Howe, L. R., Leevers, S. J., Gómez, N., Nakielny, S., Cohen, P., & Marshall, C. J. (1992) · Cell · doi:10.1016/0092-8674(92)90361-f · Cited by 801
Antibodies against β-Amyloid Slow Cognitive Decline in Alzheimer's Disease
Hock, C., Konietzko, U., Streffer, J. R., Tracy, J., Signorell, A., Müller-Tillmanns, B., Lemke, U., Henke, K., Moritz, E., Garcia, E., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00294-0 · Cited by 777
Liu, F., Grundke‐Iqbal, I., Iqbal, K., & Gong, C. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04391.x · Cited by 759
Gnahn, H., Hefti, F., Heumann, R., Schwab, M. E., & Thoenen, H. (1983) · Developmental Brain Research · doi:10.1016/0165-3806(83)90107-4 · Cited by 719
Neurotrophin Signaling Through the P75 Neurotrophin Receptor
Roux, P. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00016-3 · Cited by 717
DeKosky, S. T., Ikonomovic, M. D., Styren, S. D., Beckett, L., Wisniewski, S., Bennett, D. A., Cochran, E. J., Kordower, J. H., & Mufson, E. J. (2002) · Annals of Neurology · doi:10.1002/ana.10069 · Cited by 686
Self-citationAuld, D. S., Kornecook, T. J., Bastianetto, S., & Quirion, R. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00079-5 · Cited by 666
Activation of the Sphingomyelin Cycle Through the Low-Affinity Neurotrophin Receptor
Dobrowsky, R. T., Werner, M. H., Castellino, A. M., Chao, M. V., & Hannun, Y. A. (1994) · Science · doi:10.1126/science.8079174 · Cited by 584
Bierer, L. M., Haroutunian, V., Gabriel, S., Knott, P. J., Carlin, L. S., Purohit, D. P., Perl, D. P., Schmeidler, J., Kanof, P., & Davis, K. L. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64020749.x · Cited by 580
Dissection of the protein kinase cascade by which nerve growth factor activates MAP kinases
Gómez, N., & Cohen, P. (1991) · Nature · doi:10.1038/353170a0 · Cited by 569
Extracellular-signal-regulated kinase signalling in neurons
Grewal, S. S., York, R. D., & Stork, P. J. (1999) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(99)00010-0 · Cited by 555
CHANGES IN BRAIN CHOLINESTERASES IN SENILE DEMENTIA OF ALZHEIMER TYPE
PERRY, E. K., PERRY, R. H., BLESSED, G., & TOMLINSON, B. E. (1978) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1978.tb00545.x · Cited by 555
Stephens, R. M., Loeb, D. M., Copeland, T. D., Pawson, T., Greene, L. A., & Kaplan, D. R. (1994) · Neuron · doi:10.1016/0896-6273(94)90223-2 · Cited by 541
Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions
Bennett, D. A., Schneider, J. A., Bienias, J. L., Evans, D. A., & Wilson, R. S. (2005) · Neurology · doi:10.1212/01.wnl.0000152982.47274.9e · Cited by 537
Bamji, S. X., Majdan, M., Pozniak, C. D., Belliveau, D. J., Aloyz, R., Kohn, J., Causing, C. G., & Miller, F. D. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.4.911 · Cited by 506
Cholinergic Markers in Elderly Patients With Early Signs of Alzheimer Disease
Davis, K. L. (1999) · JAMA · doi:10.1001/jama.281.15.1401 · Cited by 492
Fahnestock, M., Michalski, B., Xu, B., & Coughlin, M. D. (2001) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2001.1016 · Cited by 490
Competitive Signaling Between TrkA and p75 Nerve Growth Factor Receptors Determines Cell Survival
Yoon, S. O., Casaccia-Bonnefil, P., Carter, B., & Chao, M. V. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-09-03273.1998 · Cited by 482
Hefti, F., Hartikka, J., & Knusel, B. (1989) · Neurobiology of Aging · doi:10.1016/0197-4580(89)90118-8 · Cited by 466
Neuropathologic Substrate of Mild Cognitive Impairment
Markesbery, W. R., Schmitt, F. A., Kryscio, R. J., Davis, D. G., Smith, C. D., & Wekstein, D. R. (2006) · Archives of Neurology · doi:10.1001/archneur.63.1.38 · Cited by 460
Doody, R. S., Gavrilova, S. I., Sano, M., Thomas, R. G., Aisen, P. S., Bachurin, S. O., Seely, L., & Hung, D. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61074-0 · Cited by 460
Nagele, R. G., D’Andrea, M. R., Anderson, W. J., & Wang, H.-Y. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00460-2 · Cited by 455
M1 Receptors Play a Central Role in Modulating AD-like Pathology in Transgenic Mice
Caccamo, A., Oddo, S., Billings, L. M., Green, K. N., Martinez-Coria, H., Fisher, A., & LaFerla, F. M. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.020 · Cited by 417
Human neuronal nicotinic receptors
Gotti, C., Fornasari, D., & Clementi, F. (1997) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00034-8 · Cited by 416
Looking Backward to Move Forward: Early Detection of Neurodegenerative Disorders
DeKosky, S. T., & Marek, K. (2003) · Science · doi:10.1126/science.1090349 · Cited by 406
Cholinergic nucleus basalis tauopathy emerges early in the aging‐MCI‐AD continuum
Mesulam, M., Shaw, P., Mash, D., & Weintraub, S. (2004) · Annals of Neurology · doi:10.1002/ana.20100 · Cited by 374
Cholinesterases: New Roles in Brain Function and in Alzheimer's Disease
Giacobini, E. (2003) · Neurochemical Research · doi:10.1023/a:1022869222652 · Cited by 371
Bruno, M. A., & Cuello, A. C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510645103 · Cited by 344
Pearson, R. C. A., Sofroniew, M. V., Cuello, A. C., Powell, T. P. S., Eckenstein, F., Esiri, M. M., & Wilcock, G. K. (1983) · Brain Research · doi:10.1016/0006-8993(83)90046-x · Cited by 334
Skaper, S. (2008) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152708783885174 · Cited by 326
Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons
Ginsberg, S. D., Hemby, S. E., Lee, V. M.-Y., Eberwine, J. H., & Trojanowski, J. Q. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200007)48:1<77::aid-ana12>3.0.co;2-a · Cited by 315
Self-citationApfel, S. C. (2002) · International Review of Neurobiology · doi:10.1016/s0074-7742(02)50083-0 · Cited by 304
Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction
Mufson, E. J., Ginsberg, S. D., Ikonomovic, M. D., & DeKosky, S. T. (2003) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(03)00068-1 · Cited by 295
Self-citationNeurotrophins Induce Death of Hippocampal Neurons via the p75 Receptor
Friedman, W. J. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-17-06340.2000 · Cited by 291
A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection
McArthur, J. C., Yiannoutsos, C., Simpson, D. M., Adornato, B. T., Singer, E. J., Hollander, H., Marra, C., Rubin, M., Cohen, B. A., Tucker, T., et al. (2000) · Neurology · doi:10.1212/wnl.54.5.1080 · Cited by 286
Tuszynski, M., U, H., Amaral, D., & Gage, F. (1990) · The Journal of Neuroscience · doi:10.1523/jneurosci.10-11-03604.1990 · Cited by 282
Krishnan, K. R. R., Charles, H. C., Doraiswamy, P. M., Mintzer, J., Weisler, R., Yu, X., Perdomo, C., Ieni, J. R., & Rogers, S. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.11.2003 · Cited by 282
Mufson, E. J., Bothwell, M., & Kordower, J. H. (1989) · Experimental Neurology · doi:10.1016/0014-4886(89)90124-6 · Cited by 279
Self-citationChan‐Palay, V. (1988) · Journal of Comparative Neurology · doi:10.1002/cne.902730409 · Cited by 273
Vetter, M. L., Martin-Zanca, D., Parada, L. F., Bishop, J. M., & Kaplan, D. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.13.5650 · Cited by 270
Structural and Functional Properties of the TRK Family of Neurotrophin Receptors
BARBACID, M. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb26693.x · Cited by 268
Neurobiology of Alzheimer′s disease
Mohandas, E., Rajmohan, V, & Raghunath, B. (2009) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.44908 · Cited by 268
Rogers, S. L., Doody, R. S., Pratt, R. D., & Ieni, J. R. (2000) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(00)00067-5 · Cited by 265
Ginsberg, S. D., Che, S., Wuu, J., Counts, S. E., & Mufson, E. J. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03764.x · Cited by 255
Self-citationCholinesterase inhibitor treatment alters the natural history of Alzheimer's disease
Lopez, O. L. (2002) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.3.310 · Cited by 255
Vaillant, A. R., Mazzoni, I., Tudan, C., Boudreau, M., Kaplan, D. R., & Miller, F. D. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.5.955 · Cited by 254
Morse, J., Wiegand, S., Anderson, K., You, Y., Cai, N., Carnahan, J., Miller, J., DiStefano, P., Altar, C., & Lindsay, R. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-10-04146.1993 · Cited by 251
Roles for the pro-neurotrophin receptor sortilin in neuronal development, aging and brain injury
Jansen, P., Giehl, K., Nyengaard, J. R., Teng, K., Lioubinski, O., Sjoegaard, S. S., Breiderhoff, T., Gotthardt, M., Lin, F., Eilers, A., et al. (2007) · Nature Neuroscience · doi:10.1038/nn2000 · Cited by 248
Higgins, G. A., Koh, S., Chen, K. S., & Gage, F. H. (1989) · Neuron · doi:10.1016/0896-6273(89)90038-x · Cited by 244
Mufson, E. J., Ma, S. Y., Cochran, E. J., Bennett, D. A., Beckett, L., Jaffar, S., Saragovi, H. U., & Kordower, J. H. (2000) · The Journal of Comparative Neurology · doi:10.1002/1096-9861(20001106)427:1<19::aid-cne2>3.0.co;2-a · Cited by 243
Self-citationGilmor, M. L., Erickson, J. D., Varoqui, H., Hersh, L. B., Bennett, D. A., Cochran, E. J., Mufson, E. J., & Levey, A. I. (1999) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19990906)411:4<693::aid-cne13>3.0.co;2-d · Cited by 239
Self-citationZUCKER, S., HYMOWITZ, M., CONNER, C., ZARRABI, H. M., HUREWITZ, A. N., MATRISIAN, L., BOYD, D., NICOLSON, G., & MONTANA, S. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07687.x · Cited by 236
Increased proNGF Levels in Subjects with Mild Cognitive Impairment and Mild Alzheimer Disease
Peng, S., Wuu, J., Mufson, E. J., & Fahnestock, M. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.6.641 · Cited by 236
Self-citationDescamps, S., Toillon, R.-A., Adriaenssens, E., Pawlowski, V., Cool, S. M., Nurcombe, V., Le Bourhis, X., Boilly, B., Peyrat, J.-P., & Hondermarck, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010499200 · Cited by 234
Liu, H.-X., Brumovsky, P., Schmidt, R., Brown, W., Payza, K., Hodzic, L., Pou, C., Godbout, C., & Hökfelt, T. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161293598 · Cited by 230
The p75 neurotrophin receptor and neuronal apoptosis
Barrett, G. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00056-8 · Cited by 226
DeKosky, D. S. T., Harbaugh, R. E., Schmitt, F. A., Bakay, R. A. E., Chui, H. C., Knopman, D. S., Reeder, T. M., Shetter, A. G., Senter, H. J., Markesbery, W. R., et al. (1992) · Annals of Neurology · doi:10.1002/ana.410320505 · Cited by 224
Counts, S. E., & Mufson, E. J. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.4.263 · Cited by 222
Self-citationNeurotrophins and their receptors: signaling trios in complex biological systems
Teng, K. K., & Hempstead, B. L. (2004) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-3099-3 · Cited by 222
Wright, C. I., Geula, C., & Mesulam, M. ‐. (1993) · Annals of Neurology · doi:10.1002/ana.410340312 · Cited by 219
Trojanowski, J. Q., & Lee, V. M. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.15.8529836 · Cited by 216
Cholinergic enhancement of frontal lobe activity in mild cognitive impairment
Saykin, A. J., Wishart, H. A., Rabin, L. A., Flashman, L. A., McHugh, T. L., Mamourian, A. C., & Santulli, R. B. (2004) · Brain · doi:10.1093/brain/awh177 · Cited by 216
Hellström-Lindahl, E., Mousavi, M., Zhang, X., Ravid, R., & Nordberg, A. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00030-3 · Cited by 215
Activation of Rac GTPase by p75 Is Necessary for c-jun N-Terminal Kinase-Mediated Apoptosis
Harrington, A. W., Kim, J. Y., & Yoon, S. O. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-01-00156.2002 · Cited by 208
Eiden, L. E. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70062227.x · Cited by 207
Mufson, E. J., Ma, S. Y., Dills, J., Cochran, E. J., Leurgans, S., Wuu, J., Bennett, D. A., Jaffar, S., Gilmor, M. L., Levey, A. I., et al. (2002) · Journal of Comparative Neurology · doi:10.1002/cne.10122 · Cited by 197
Self-citationHamanoue, M., Middleton, G., Wyatt, S., Jaffray, E., Hay, R. T., & Davies, A. M. (1999) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1999.0770 · Cited by 197
Brann, A. B., Scott, R., Neuberger, Y., Abulafia, D., Boldin, S., Fainzilber, M., & Futerman, A. H. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-19-08199.1999 · Cited by 194
Cotman, C. W., Matthews, D. A., Taylor, D., & Lynch, G. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.12.3473 · Cited by 191
Reduction of cortical TrkA but not p75NTR protein in early‐stage Alzheimer's disease
Counts, S. E., Nadeem, M., Wuu, J., Ginsberg, S. D., Saragovi, H. U., & Mufson, E. J. (2004) · Annals of Neurology · doi:10.1002/ana.20233 · Cited by 183
Self-citationTuszynski, M. H., Sang U, H., Yoshida, K., & Gage, F. H. (1991) · Annals of Neurology · doi:10.1002/ana.410300502 · Cited by 183
Reinnervation of the hippocampal perforant pathway zone in Alzheimer's disease
Hyman, B. T., Kromer, L. J., & van Hoesen, G. W. (1987) · Annals of Neurology · doi:10.1002/ana.410210307 · Cited by 177
Galanin – 25 years with a multitalented neuropeptide: Galanin, galanin receptors and drug targets
Mitsukawa, K., Lü, X., & Bartfai, T. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8153-8 · Cited by 177
Fahnestock, M., Yu, G., Michalski, B., Mathew, S., Colquhoun, A., Ross, G. M., & Coughlin, M. D. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02360.x · Cited by 171
Blasko, I., Lederer, W., Oberbauer, H., Walch, T., Kemmler, G., Hinterhuber, H., Marksteiner, J., & Humpel, C. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000089137 · Cited by 170
Francis, P. T., Nordberg, A. K., & Arnold, S. E. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.12.010 · Cited by 164
Lorenzl, S., Albers, D. S., LeWitt, P. A., Chirichigno, J. W., Hilgenberg, S. L., Cudkowicz, M. E., & Beal, M. F. (2003) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00398-2 · Cited by 164
Tuszynski, M. H., Roberts, J. A., Senut, M., U, H. S., & Gage, F. H. (1996) · PubMed · Cited by 164
Mufson, E. J., Cochran, E., Benzing, W., & Kordower, J. H. (1993) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000107329 · Cited by 162
Self-citationSaper, C. B., German, D. C., & White, C. L. (1985) · Neurology · doi:10.1212/wnl.35.8.1089 · Cited by 159
Jang, S.-W., Okada, M., Sayeed, I., Xiao, G., Stein, D., Jin, P., & Ye, K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706662104 · Cited by 158
Foehr, E. D., Lin, X., O'Mahony, A., Geleziunas, R., Bradshaw, R. A., & Greene, W. C. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-20-07556.2000 · Cited by 154
Brain acetylcholinesterase activity in mild cognitive impairment and early Alzheimer's disease
Rinne, J. O. (2003) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.1.113 · Cited by 153
Roux, P. P., Bhakar, A. L., Kennedy, T. E., & Barker, P. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011520200 · Cited by 152
Teaktong, T., Graham, A., Court, J., Perry, R., Jaros, E., Johnson, M., Hall, R., & Perry, E. (2003) · Glia · doi:10.1002/glia.10132 · Cited by 151
Brann, A. B., Tcherpakov, M., Williams, I. M., Futerman, A. H., & Fainzilber, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109862200 · Cited by 151
Trks: Signal transduction and intracellular pathways
Klesse, L. J., & Parada, L. F. (1999) · Microscopy Research and Technique · doi:10.1002/(sici)1097-0029(19990515/01)45:4/5<210::aid-jemt4>3.0.co;2-f · Cited by 151
The Second Galanin Receptor GalR2 Plays a Key Role in Neurite Outgrowth from Adult Sensory Neurons
Mahoney, S.-A., Hosking, R., Farrant, S., Holmes, F. E., Jacoby, A. S., Shine, J., Iismaa, T. P., Scott, M. K., Schmidt, R., & Wynick, D. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-02-00416.2003 · Cited by 150
Gene Expression Profiles of Cholinergic Nucleus Basalis Neurons in Alzheimer's Disease
Mufson, E. J., Counts, S., & Ginsberg, S. D. (2002) · Neurochemical Research · doi:10.1023/a:1020952704398 · Cited by 147
Self-citationA TrkA-to-p75NTR molecular switch activates amyloid β-peptide generation during aging
Costantini, C., Weindruch, R., Della Valle, G., & Puglielli, L. (2005) · Biochemical Journal · doi:10.1042/bj20050700 · Cited by 147
Salehi, A., Verhaagen, J., Dijkhuizen, P. A., & Swaab, D. F. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00273-4 · Cited by 144
Edwards, R. H., Selby, M. J., Garcia, P. D., & Rutter, W. J. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68715-0 · Cited by 137
Winkler, J., Ramirez, G. A., Kuhn, H. G., Peterson, D. A., Day‐Lollini, P. A., Stewart, G. R., Tuszynski, M. H., Gage, F. H., & Thal, L. J. (1997) · Annals of Neurology · doi:10.1002/ana.410410114 · Cited by 137
Mechanisms Behind the Neuroprotective Actions of Cholinesterase Inhibitors in Alzheimer Disease
Nordberg, A. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000213804.59187.2d · Cited by 134
Rattenholl, A., Lilie, H., Grossmann, A., Stern, A., Schwarz, E., & Rudolph, R. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02232.x · Cited by 132
Hartikka, J., & Hefti, F. F. (1988) · Journal of Neuroscience Research · doi:10.1002/jnr.490210227 · Cited by 128
Nerve Growth Factor: Structure, Function and Therapeutic Implications for Alzheimers Disease
Lad, S., Neet, K., & Mufson, E. (2003) · Current Drug Target -CNS & Neurological Disorders · doi:10.2174/1568007033482724 · Cited by 127
Self-citationKimpinski, K., & Mearow, K. M. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1043 · Cited by 121
Advances in the pharmacotherapy of Alzheimer's disease.
Gauthier, S. G. (2002) · Europe PMC (PubMed Central) · Cited by 117
α7 Nicotinic Receptor Up-regulation in Cholinergic Basal Forebrain Neurons in Alzheimer Disease
Counts, S. E., He, B., Che, S., Ikonomovic, M. D., DeKosky, S. T., Ginsberg, S. D., & Mufson, E. J. (2007) · Archives of Neurology · doi:10.1001/archneur.64.12.1771 · Cited by 115
Self-citationDeFreitas, M. F., McQuillen, P. S., & Shatz, C. J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-14-05121.2001 · Cited by 114
Ginsberg, S. D., Che, S., Counts, S. E., & Mufson, E. J. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03641.x · Cited by 111
Self-citationMulti‐tasking by the p75 neurotrophin receptor: sortilin things out?
Bronfman, F. C., & Fainzilber, M. (2004) · EMBO Reports · doi:10.1038/sj.embor.7400219 · Cited by 108
Gentry, J. J., Casaccia-Bonnefil, P., & Carter, B. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.11.7558 · Cited by 108
Cholinotrophic Molecular Substrates of Mild Cognitive Impairment in the Elderly
Mufson, E., Counts, S., Fahnestock, M., & Ginsberg, S. (2007) · Current Alzheimer Research · doi:10.2174/156720507781788855 · Cited by 104
Self-citationAshcroft, M. A., Stephens, R. M., Hallberg, B., Downward, J., & Kaplan, D. R. (1999) · Oncogene · doi:10.1038/sj.onc.1202814 · Cited by 103
Neuronal size and density in the nucleus basalis of Meynert in Alzheimer's disease
Rinne, J. O., Paljärvi, L., & Rinne, U. K. (1987) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(87)90260-7 · Cited by 102
Sortilin, SorCS1b, and SorLA Vps10p sorting receptors, are novel γ-secretase substrates
Nyborg, A. C., Ladd, T. B., Zwizinski, C. W., Lah, J. J., & Golde, T. E. (2006) · Molecular Neurodegeneration · doi:10.1186/1750-1326-1-3 · Cited by 98
Mamidipudi, V., & Wooten, M. W. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10244 · Cited by 97
Holmes, C. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.039321 · Cited by 97
Profiles of matrix metalloproteinases and their inhibitors in plasma of patients with dementia
Lorenzl, S., Büerger, K., Hampel, H., & Beal, M. F. (2007) · International Psychogeriatrics · doi:10.1017/s1041610207005790 · Cited by 96
Suppression of Nerve Growth Factor-induced Neuronal Differentiation of PC12 Cells
Kamata, H., Tanaka, C., Yagisawa, H., Matsuda, S., Gotoh, Y., Nishida, E., & Hirata, H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.33018 · Cited by 95
A function–structure model for NGF‐activated TRK
Cunningham, M. E., & Greene, L. A. (1998) · The EMBO Journal · doi:10.1093/emboj/17.24.7282 · Cited by 94
Longo, F., Yang, T., Knowles, J., Xie, Y., Moore, L., & Massa, S. (2007) · Current Alzheimer Research · doi:10.2174/156720507783018316 · Cited by 90
AF150(S) and AF267B: M1 muscarinic agonists as innovative therapies for alzheimer’s disease
Fisher, A., Brandeis, R., Bar-Ner, R. H. N., Kliger-Spatz, M., Natan, N., Sonego, H., Marcovitch, I., & Pittel, Z. (2002) · Journal of Molecular Neuroscience · doi:10.1007/s12031-002-0025-3 · Cited by 89
Fisher, A. (2008) · Neurodegenerative Diseases · doi:10.1159/000113712 · Cited by 87
Bruno, M. A., Clarke, P. B. S., Seltzer, A., Quirion, R., Burgess, K., Cuello, A. C., & Saragovi, H. U. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1508-04.2004 · Cited by 87
Ruberg, M., Mayo, W., Brice, A., Duyckaerts, C. J., Hauw, J., Simon, H., Moal, M. L., & Agid, Y. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90086-j · Cited by 86
Frade, J. M. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.7.1139 · Cited by 81
Single cell gene expression profiling in Alzheimer’s disease
Ginsberg, S. D., Che, S., Counts, S., & Mufson, E. J. (2006) · NeuroRx · doi:10.1016/j.nurx.2006.05.007 · Cited by 81
Self-citationTranscriptional and conformational changes of the tau molecule in Alzheimer's disease
Hyman, B. T., Augustinack, J. C., & Ingelsson, M. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.06.015 · Cited by 79
Recent Developments in the Drug Treatment of Alzheimer??s Disease
Sramek, J. J., & Cutler, N. R. (1999) · Drugs & Aging · doi:10.2165/00002512-199914050-00004 · Cited by 77
Boutajangout, A., Boom, A., Leroy, K., & Brion, J. P. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.09.011 · Cited by 77
Galanin attenuates β-amyloid (Aβ) toxicity in rat cholinergic basal forebrain neurons
Ding, X., MacTavish, D., Kar, S., & Jhamandas, J. H. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.08.016 · Cited by 75
Neurotrophic Factor Therapy – Prospects and Problems
Apfel, S. C. (2001) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2001.055 · Cited by 72
Small, D. H., Maksel, D., Kerr, M. L., Ng, J., Hou, X., Chu, C., Mehrani, H., Unabia, S., Azari, M. F., Loiacono, R., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04444.x · Cited by 69
Chu, Y., Cochran, E. J., Bennett, D. A., Mufson, E. J., & Kordower, J. H. (2001) · Journal of Comparative Neurology · doi:10.1002/cne.1284 · Cited by 69
Self-citationCholinesterase inhibitors reduce cortical Aβ in dementia with Lewy bodies
Ballard, C. G., Chalmers, K. A., Todd, C., McKeith, I. G., O’Brien, J. T., Wilcock, G., Love, S., & Perry, E. K. (2007) · Neurology · doi:10.1212/01.wnl.0000261920.03297.64 · Cited by 67
Counts, S. E. (2003) · Molecular Interventions · doi:10.1124/mi.3.3.137 · Cited by 64
Self-citationAndjelković, M., Suidan, H. S., Meier, R., Frech, M., Alessi, D. R., & Hemmings, B. A. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2510195.x · Cited by 62
Galanin – 25 years with a multitalented neuropeptide
Hobson, S. A., Bacon, A., Elliott‐Hunt, C. R., Holmes, F. E., Kerr, N. C. H., Pope, R. J. P., Vanderplank, P. A., & Wynick, D. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8154-7 · Cited by 62
Jhamandas, J. H., Harris, K. H., MacTavish, D., & Jassar, B. S. (2002) · Journal of Neurophysiology · doi:10.1152/jn.00416.2001 · Cited by 59
Nerve growth factor and cholinergic CNS neurons studied in organotypic brain slices
Humpel, C., & Weis, C. (2002) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6139-5_23 · Cited by 56
Cortical biochemistry in MCI and Alzheimer disease: Lack of correlation with clinical diagnosis
Forman, M. S., Mufson, E. J., Leurgans, S., Pratico, D., Joyce, S., Leight, S., Lee, V. M.-Y., & Trojanowski, J. Q. (2007) · Neurology · doi:10.1212/01.wnl.0000256373.39415.b1 · Cited by 55
Self-citationNerve Growth Factor Treatment in Dementia
Jönhagen, M. E. (2000) · Alzheimer Disease and Associated Disorders · doi:10.1097/00002093-200000001-00006 · Cited by 53
Charles, V., Mufson, E. J., Friden, P. M., Bartus, R. T., & Kordower, J. H. (1996) · Brain Research · doi:10.1016/0006-8993(96)00398-8 · Cited by 53
Self-citationCounts, S., Chen, E., Che, S., Ikonomović, M. D., Wuu, J., Ginsberg, S. D., DeKosky, S. T., & Mufson, E. J. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000090906 · Cited by 52
Self-citationM1 Muscarinic Agonists Target Major Hallmarks of Alzheimers Disease – an Update
Fisher, A. (2007) · Current Alzheimer Research · doi:10.2174/156720507783018163 · Cited by 50
Counts, S., Perez, S. E., & Mufson, E. J. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8159-2 · Cited by 49
Self-citationRahman, A., Grundke, I., & Iqbal, K. (2005) · Neurochemical Research · doi:10.1007/s11064-005-2483-9 · Cited by 48
Nerve growth factor stimulates MAPK via the low affinity receptor p75LNTR
Susen, K., Heumann, R., & Blöchl, A. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01628-2 · Cited by 48
Hughes, A. L., Messineo-Jones, D., Lad, S. P., & Neet, K. (2001) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20010101)63:1<10::aid-jnr2>3.0.co;2-r · Cited by 48
Bhakar, A., Roux, P. P., Lachance, C., Kryl, D., Zeindler, C., & Barker, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.30.21443 · Cited by 47
Neuronal gene expression profiling: uncovering the molecular biology of neurodegenerative disease
Mufson, E. J., Counts, S., Che, S., & Ginsberg, S. D. (2006) · Progress in brain research · doi:10.1016/s0079-6123(06)58010-0 · Cited by 41
Self-citationNeurotrophins and Alzheimer's disease: Beyond the cholinergic neurons
Knüsel, B., & Gao, H. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00193-2 · Cited by 41
Hatanaka, H., Nihonmatsu, I., & Tsukui, H. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90787-2 · Cited by 40
Ginsberg, S. D., & Martin, L. J. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00136-5 · Cited by 40
Self-citationA move to sort life from death
Kaplan, D. R., & Miller, F. D. (2004) · Nature · doi:10.1038/427798a · Cited by 39
Counts, S., He, B., Che, S., Ginsberg, S. D., & Mufson, E. J. (2008) · Neurodegenerative Diseases · doi:10.1159/000113710 · Cited by 39
Self-citationTogo, T., Akiyama, H., Iseki, E., Uchikado, H., Kondo, H., Ikeda, K., Tsuchiya, K., de Silva, R., Lees, A., & Kosaka, K. (2004) · Acta Neuropathologica · doi:10.1007/s00401-004-0842-2 · Cited by 38
NGF-mediated synaptic sprouting in the cerebral cortex of lesioned primate brain
Burgos, I., Cuello, A. C., Liberini, P., Pioro, E., & Masliah, E. (1995) · Brain Research · doi:10.1016/0006-8993(95)00696-n · Cited by 38
Molecules Involved in Reactive Sprouting in the Hippocampus
Savaskan, N. Ε., & Nitsch, R. (2001) · Reviews in the Neurosciences · doi:10.1515/revneuro.2001.12.3.195 · Cited by 38
Galanin plasticity in the cholinergic basal forebrain in Alzheimer’s disease and transgenic mice
Mufson, E. J., Counts, S., Perez, S. E., & Binder, L. I. (2005) · Neuropeptides · doi:10.1016/j.npep.2004.12.005 · Cited by 37
Self-citationGalanin – 25 years with a multitalented neuropeptide
Crawley, J. N. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8158-3 · Cited by 37
Increased Alpha 7 Nicotinic Acetylcholine Receptor Protein Levels in Alzheimer’s Disease Patients
Chu, L., Ma, E. S. K., Lam, K., Chan, M. F., & Lee, D. H. S. (2005) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000082661 · Cited by 36
Alzheimer's Disease:Progress in the Development of Anti-amyloid Disease-Modifying Therapies
Christensen, D. D. (2007) · CNS Spectrums · doi:10.1017/s1092852900020629 · Cited by 34
Cosgaya, J. M., & Shooter, E. M. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00573.x · Cited by 32
Planas, B., Kolb, P. E., Raskind, M. A., & Miller, M. A. (1997) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19970324)379:4<563::aid-cne7>3.0.co;2-0 · Cited by 30
Insights into the interaction of sortilin with proneurotrophins: A computational approach
Paiardini, A., & Caputo, V. (2008) · Neuropeptides · doi:10.1016/j.npep.2007.11.004 · Cited by 29
Chapter 17 Gene therapy in the CNS: intracerebral grafting of genetically modified cells
Gage, F. H., Rosenberg, M. B., Tuszynskil, M. H., Yoshida, K., Armstrong, D. M., Hayes, R. C., & Friedmann, T. (1990) · Progress in brain research · doi:10.1016/s0079-6123(08)63178-7 · Cited by 28
Survival, growth and function of damaged cholinergic neurons
Gage, F. H., Tuszynski, M. H., Chen, K. S., Armstrong, D. L., & Buzsáki, G. (1989) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-0348-9138-7_26 · Cited by 28
Nerve Growth Factor Systems in Alzheimer’s Disease
Mufson, E. J., & Kordower, J. H. (1999) · Cerebral cortex · doi:10.1007/978-1-4615-4885-0_19 · Cited by 25
Self-citationClinical and economic outcomes - friend or foe?
Wimo, A. B. (2007) · International Psychogeriatrics · doi:10.1017/s1041610207004930 · Cited by 16
Role for peroxisome proliferator-activated receptor-gamma in Alzheimer's disease.
van Geel (2001) · Open Repository and Bibliography (University of Luxembourg) · doi:10.1002/1531-8249(20010201)49:2 · Cited by 7
Khan (2000) · doi:10.1002/1531-8249(200008)48:2
Cited by
The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
Hampel, H., Mesulam, M.-M., Cuello, A. C., Farlow, M. R., Giacobini, E., Grossberg, G. T., Khachaturian, A. S., Vergallo, A., Cavedo, E., Snyder, P. J., et al. (2018) · Brain · doi:10.1093/brain/awy132 · Cited by 1,918
The cholinergic system in aging and neuronal degeneration
Schliebs, R., & Arendt, T. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.11.058 · Cited by 1,047
Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options
Cummings, J. L., Tong, G., & Ballard, C. (2019) · Journal of Alzheimer's Disease · doi:10.3233/jad-180766 · Cited by 588
Drug treatments in Alzheimer’s disease
Briggs, R., Kennelly, S. P., & O’Neill, D. (2016) · Clinical Medicine · doi:10.7861/clinmedicine.16-3-247 · Cited by 571
Tyler, C. R., & Allan, A. M. (2014) · Current Environmental Health Reports · doi:10.1007/s40572-014-0012-1 · Cited by 537
Metadata
- Authors
- Mufson, E. J., Counts, S. E., Perez, S. E., & Ginsberg, S. D.
- Venue
- Expert Review of Neurotherapeutics
- Publisher
- Informa UK Limited
- Published
- 2008-11
- Volume
- 8
- Issue
- 11
- Pages
- 1703-1718
- ISSN
- 1473-7175 (ISSN-L)
- 1744-8360
- OpenAlex
- W2097391583
- Cited by
- 587
- References
- 191
- FWCI
- 9.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.